The Accelerated Community Oncology Research Network (ACORN) , a national oncology-focused Contract Research Organization (CRO) and clinical trial network, has announced that it has named Tara Webb as Senior Director of Business Development. Webb brings a successful record of establishing and cultivating CRO relationships. “Tara Webb has an exceptional background of work in the CRO field and is widely respected for her industry knowledge, capabilities and integrity,” remarked Edward J. Stepanski, PhD, Chief Operations Officer of ACORN. “Her responsibilities at ACORN CRO will include presenting ACORN’s capabilities to pharmaceutical companies and emerging biotechs, forging alliances with key accounts and providing customer service oversight on behalf of clients. “Most recently, Webb served as Senior Director, Business Development for i3 Statprobe, where she was responsible for developing new business opportunities and strengthening current client relationships both nationally and internationally.ACORN CRO will provide Webb with the platform to focus her energies exclusively in the field of oncology, thus enabling closer working relationships with a select group of sponsors. “Tara Webb is an excellent fit with our organization as she is known for her dedication and determination to consistently provide her clients and their projects with uncompromising standards of quality,” stated Steve Coplon, ACORN CEO. “With a decade of research experience augmented by a strong, technological background, she will provide excellent representation of ACORN CRO’s scientific strength, unprecedented community oncology relationships, and ACORN’s proprietary technology, including Guardian EDCT,” added Coplon.Webb holds a M.S. in Organizational Leadership & Administration and a B.S. in Health Administration (Accelerated Program) from Concordia College, Ann Arbor, Michigan.
